Dipna Pharma. Stock Price Analysis and Quick Research Report. Is Dipna Pharma. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dipna Pharma.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dipna Pharma. has a PE ratio of 49.4198963218958 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dipna Pharma. has ROA of 0.7344% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dipna Pharma. has a Current ratio of 1.5569.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dipna Pharma. has a ROE of 2.563%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dipna Pharma. has a Debt to Equity ratio of 0.4474 which means that the company has low proportion of debt in its capital.

• Sales growth: Dipna Pharma. has reported revenue growth of -23.9873% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dipna Pharma. for the current financial year is 3.13559952960802%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dipna Pharma. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dipna Pharma. is Rs 0.4051. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dipna Pharma. in Ticker for free. Also, one can get the intrinsic value of Dipna Pharma. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dipna Pharma. FAQs

Q1. What is Dipna Pharma. share price today?
Ans: The current share price of Dipna Pharma. is Rs 20.02.

Q2. What is the market capitalisation of Dipna Pharma.?
Ans: Dipna Pharma. has a market capitalisation of Rs 48.1385905 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dipna Pharma.?
Ans: The PE ratio of Dipna Pharma. is 49.4198963218958 and the P/B ratio of Dipna Pharma. is 1.25058562638598, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dipna Pharma. share?
Ans: The 52-week high share price of Dipna Pharma. is Rs 26.31, and the 52-week low share price of Dipna Pharma. is Rs 6.4.

Q5. Does Dipna Pharma. pay dividends?
Ans: Currently, Dipna Pharma. does not pay dividends. Dividend yield of Dipna Pharma. is around 0%.

Q6. What are the face value and book value of Dipna Pharma. shares?
Ans: The face value of Dipna Pharma. shares is Rs 10, while the book value per share of Dipna Pharma. is around Rs 16.0085. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dipna Pharma.?
Ans: Dipna Pharma. has a total debt of Rs 17.2228 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dipna Pharma.?
Ans: The ROE of Dipna Pharma. is 2.563% and ROCE of Dipna Pharma. is 6.9548%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dipna Pharma. a good buy for the long term?
Ans: The Dipna Pharma. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dipna Pharma. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dipna Pharma. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dipna Pharma.’s financials?
Ans: You can review Dipna Pharma.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.